Jakob Schäfer

Jakob Schäfer is a Physician Scientist at Aalborg University Hospital under the Faculty of Health Sciences, affiliated with the Department of Neurology and Neurophysiology. His research focuses on Multiple Sclerosis and its treatment dynamics, particularly disease-modifying therapies like dimethyl fumarate and teriflunomide.

Research Themes:

• Longitudinal cohort studies of MS progression
• Phenotype transition predictors in MS patients
• Cardiovascular risks associated with MS treatments
• Danish national registry-based clinical research
• Neuroimmunology and pharmacological interventions

Publications (2024–2025) analyze hypertension risks with teriflunomide, MS treatment patterns, and transitions from relapsing-remitting to secondary progressive MS using advanced statistical models. His work leverages data from the Danish Multiple Sclerosis Registry for population-level insights.